Medical Digest & Congress Report

Advancing Cardiovascular Protection with Incretins and SGLT-2 Inhibitors: EASD-ESC Joint Session - report from EASD 2026 Oct 16, 2026 00:08:47 Dr. Åke Sjöholm presents key insights from the EASD-ESC joint session on advancing cardiovascular protection with incretins and SGLT-2 inhibitors at the EASD 2026 Congress. This brief highlights clinical mechanisms, cardiorenal benefits, and combined therapeutic strategies to reduce cardiovascular risk and improve outcomes in patients with metabolic disease and type 2 diabetes.Video: https://medic

Changing the Trajectory of Chronic Metabolic Disease: A Hepatology Perspective on GLP-1 Care & Integrating Liver Health Beyond Steatosis - report from EASD 2026 Oct 16, 2026 00:05:47 Dr. Eric Lawitz presents a hepatologist's perspective on altering the trajectory of chronic metabolic disease at the EASD 2026 Congress. This brief highlights the evolving role of GLP-1-based therapies and strategies for integrating targeted liver health management beyond simple steatosis into comprehensive metabolic care.Video: https://medicaldigest.org/scientific-contents/interview:changing-

Patterns and Prevention of Cardiovascular Diseases - report from EASD 2026 Oct 16, 2026 00:08:34 Dr. Alexandra Kautzky-Willer presents key insights on the patterns and prevention of cardiovascular diseases at the EASD 2026 Congress. This brief highlights clinical strategies for identifying cardiovascular risk patterns, implementing targeted early preventive measures, and optimizing long-term outcomes in patients with metabolic disorders.Video: https://medicaldigest.org/scientific-contents/int

SGLT-2 Inhibitors: From Real-World Insights to Mechanistic and Oncological Frontiers - report from EASD 2026 Oct 16, 2026 00:07:13 Dr. Claudio Scafoglio presents key insights into expanding the scope of SGLT-2 inhibition at the EASD 2026 Congress. This brief highlights real-world clinical data, underlying cellular mechanisms, and emerging evidence surrounding potential oncological applications and broader therapeutic frontiers of SGLT-2 inhibitors.Video: https://medicaldigest.org/scientific-contents/interview:sglt-2-inhibitor

Making the Connections to Reduce Risk: Cardiovascular, Renal, and Metabolic Benefits of SGLT-2 Inhibitors in T2D - report from EASD 2026 Oct 16, 2026 00:10:58 Dr. Gian Paolo Fadini presents key insights into interconnected organ protection with SGLT-2 inhibitors at the EASD 2026 Congress. This brief highlights clinical evidence on the cardiovascular, renal, and metabolic benefits of SGLT2 inhibition, emphasizing strategies to reduce overall risk and optimize long-term outcomes in patients with type 2 diabetes.Video: https://medicaldigest.org/scientific-

Obesity Management Through Different Lenses: EASD-EASO Joint Session - report from EASD 2026 Oct 16, 2026 00:04:38 Dr. Matthias Blüher presents key insights from the EASD-EASO joint session on obesity management through different lenses at the EASD 2026 Congress. This brief highlights multidisciplinary approaches to weight management, combining endocrinology and obesity expertise to address metabolic complications, personalize therapeutic strategies, and improve long-term patient outcomes.Video: https://medica

ADA/EASD Consensus Report on the Management of Type 2 Diabetes - report from EASD 2026 Oct 13, 2026 00:06:58 Dr. John Bernard Buse presents key updates from the joint ADA/EASD consensus report on the management of type 2 diabetes at the EASD 2026 Congress. This brief highlights updated clinical guidelines, person-centered management strategies, holistic care approaches, and evidence-based recommendations for glucose-lowering and cardiometabolic risk reduction.Video: https://medicaldigest.org/scientific-c

Early Approvals, Real-World Insights, and Emerging Therapies in MASLD Care - report from EASD 2026 Oct 13, 2026 00:07:02 Dr. Cyrielle Caussy presents key insights from the EASD-EASL joint session on metabolic dysfunction-associated steatotic liver disease (MASLD) at the EASD 2026 Congress. This brief highlights early therapeutic approvals, real-world clinical data, and novel emerging treatments aimed at optimizing multidisciplinary care and improving outcomes for patients with MASLD and metabolic risk factors. Video

Beyond Weight Loss: A Biology-Driven Approach to Metabolic Health – Obesity as a Systemic Disease: From Adiposity to Metabolic Dysfunction - report from EASD 2026 Oct 13, 2026 00:06:21 Dr. Paolo Sbraccia presents key insights into viewing obesity as a systemic disease and adopting a biology-driven approach to metabolic health at the EASD 2026 Congress. This brief highlights the pathophysiological progression from adiposity to systemic metabolic dysfunction, emphasizing targeted therapies and clinical strategies that look beyond weight loss to optimize overall cardiometabolic out

Effect of CagriSema on Bone Biomarkers in Inadequately Controlled Type 2 Diabetes: REIMAGINE 2 - report from EASD 2026 Oct 13, 2026 00:06:06 Dr. Martin Haluzík presents key findings from the REIMAGINE 2 trial evaluating CagriSema at the EASD 2026 Congress. This brief highlights clinical data on the impact of dual amylin and GLP-1 receptor agonism on bone turnover markers, overall bone health, and metabolic parameters in participants with inadequately controlled type 2 diabetes.Video: https://medicaldigest.org/scientific-contents/interv

Retatrutide in Adults with Obesity and Type 2 Diabetes: Phase 3 TRIUMPH-2 Trial - report from EASD 2026 Oct 13, 2026 00:02:46 Dr. Stefano Del Prato presents key findings from the Phase 3 TRIUMPH-2 trial evaluating retatrutide at the EASD 2026 Congress. This brief highlights clinical evidence on the glycemic efficacy, weight reduction outcomes, and safety profile of triple receptor agonism in adults living with obesity and type 2 diabetes.Video: https://medicaldigest.org/scientific-contents/interview:retatrutide-adults-ob

Renal Outcomes and Cardiorenal Mechanisms in Type 2 Diabetes: Highlights from the FLOW and ACHIEVE-4 Trials - report from EASD 2026 Oct 13, 2026 00:04:59 Dr. Katherine Tuttle presents key insights on cardiorenal protection in type 2 diabetes at the EASD 2026 Congress, drawing from both the FLOW and ACHIEVE-4 trials. This brief highlights novel proteomic biomarker analyses explaining the pathways of kidney protection in FLOW, alongside clinical data from the ACHIEVE-4 trial comparing the renal outcomes of oral orforglipron versus insulin glargine in

Effect of CagriSema on Composite HbA1c and Body Weight Reduction Targets in Type 2 Diabetes: REIMAGINE 1 - report from EASD 2026 Oct 13, 2026 00:05:42 Dr. Akshay Jain presents key findings from the REIMAGINE 1 trial on CagriSema at the EASD 2026 Congress. This brief highlights clinical evidence on the efficacy of CagriSema in achieving composite HbA1c and significant body weight reduction targets, demonstrating the potential of dual-action therapy in managing type 2 diabetes and metabolic risk.Video: https://medicaldigest.org/scientific-contents

Early Intervention, Lasting Benefit: Reshaping the Obesity Treatment Paradigm - report from EASD 2026 Oct 13, 2026 00:08:24 Dr. Arya Sharma presents key insights into reshaping the obesity treatment paradigm through early intervention at the EASD 2026 Congress. This brief highlights the long-term clinical benefits of proactive weight management, addressing the underlying drivers of metabolic disease early, and transitioning toward sustained, lifelong therapeutic approaches for obesity.Video: https://medicaldigest.org/s

Early Approvals, Real-World Insights, and Emerging Therapies in MASLD Care - report from EASD 2026 Oct 13, 2026 00:14:01 Dr. Michael Roden presents key insights from the EASD-EASL joint session on metabolic dysfunction-associated steatotic liver disease (MASLD) at the EASD 2026 Congress. This brief highlights early therapeutic approvals, real-world clinical data, and novel emerging treatments aimed at optimizing multidisciplinary care and improving outcomes for patients with MASLD and metabolic risk factors.Video: h

The Implementation Imperative: Closing the Gap in Diabetes Care - report from EASD 2026 Oct 13, 2026 00:04:20 Dr. Amisha Wallia presents key insights from the EASD-ADA joint session on closing the implementation gap in diabetes care at the EASD 2026 Congress. This brief highlights evidence-based implementation strategies, discussing pathways to overcome system-level barriers, translate clinical guidelines into routine practice, and achieve equitable care delivery for patients with diabetes.Video: https://

ACASA-TAVI: Antithrombotic Therapy After TAVI - report from ESC 2026 Sep 10, 2026 00:05:44 Prof. Oyvind H. Lie presents trial findings on antithrombotic management following transcatheter aortic valve implantation (TAVI) at the ESC Congress 2026, evaluating optimal regimen strategies to balance ischemic risk reduction and bleeding complications.Video: https://medicaldigest.org/scientific-contents/interview:acasa-tavi-antithrombotic-therapy-after-tavi

REACT: Prevalence of Silent Atherosclerosis Across Adult Life - report from ESC 2026 Sep 10, 2026 00:06:54 Prof. Henning Bundgaard presents landmark data from the REACT study at the ESC Congress 2026, mapping the prevalence of silent atherosclerosis across early to late adulthood and highlighting the role of early vascular imaging in primary prevention.Video: https://medicaldigest.org/scientific-contents/interview:react-prevalence-silent-atherosclerosis-across-adult-life

LDL Cholesterol Management in CAD: From ARMYDA to AMUNDSEN - report from ESC 2026 Sep 10, 2026 00:10:39 Prof. Giuseppe Patti tracks the evolution of low-density lipoprotein cholesterol management in coronary artery disease at the ESC Congress 2026, drawing insights from the ARMYDA trials to the landmark AMUNDSEN study to optimize lipid-lowering strategies.Video: https://medicaldigest.org/scientific-contents/interview:ldl-cholesterol-management-cad-armyda-amundsen

Comorbidities Require Special Attention in Atrial Fibrillation - report from ESC 2026 Sep 10, 2026 00:07:47 Prof. Ratika Parkash explores the critical role of managing comorbid conditions in atrial fibrillation at the ESC Congress 2026, emphasizing tailored risk factor modification and comprehensive multidisciplinary care.Video: https://medicaldigest.org/scientific-contents/interview:comorbidities-require-special-attention-atrial-fibrillation

How to Personalise the Treatment of Atrial Fibrillation - report from ESC 2026 Sep 10, 2026 00:06:49 Prof. Helmut Puererfellner explores tailored approaches to atrial fibrillation management at the ESC Congress 2026, focusing on patient-specific symptom burdens, ablation vs. medical therapy, and targeted risk factor modification.Video: https://medicaldigest.org/scientific-contents/interview:how-personalise-treatment-atrial-fibrillation

2026 ESC Guidelines for the Management of Cardiovascular Disease and Chronic Kidney Disease Sep 10, 2026 00:05:48 Prof. Kevin Damman outlines the new 2026 ESC Guidelines for managing cardiorenal syndrome at the ESC Congress 2026, focusing on early intervention, risk stratification, and integrated treatment approaches for co-existing CVD and CKD.Video: https://medicaldigest.org/scientific-contents/interview:2026-esc-guidelines-management-cardiovascular-disease-and-chronic-kidney-disease

Practical Implementation of the ESC Atrial Fibrillation Guideline - report from ESC 2026 Sep 10, 2026 00:09:35 Prof. Michiel Rienstra discusses the practical implementation of the ESC Atrial Fibrillation Guidelines at the ESC Congress 2026, offering actionable strategies to streamline clinical workflows and optimize patient care.Video: https://medicaldigest.org/scientific-contents/interview:practical-implementation-esc-atrial-fibrillation-guideline

2026 ESC Guidelines for the Management of Heart Failure - report from ESC 2026 Sep 10, 2026 00:06:17 Prof. Marianna Adamo outlines the updated 2026 ESC Guidelines for the Management of Heart Failure at the ESC Congress 2026, highlighting essential advances in diagnosis, early therapy initiation, and disease management.Video: https://medicaldigest.org/scientific-contents/interview:2026-esc-guidelines-management-heart-failure

SWITCH SWEDEHEART: Switching Ticagrelor to Prasugrel in ACS - report from ESC 2026 Sep 10, 2026 00:10:14 Prof. Elmir Omerovic presents key results from the SWITCH SWEDEHEART trial at the ESC Congress 2026, evaluating the safety and efficacy of switching from ticagrelor to prasugrel in patients with acute coronary syndromes.Video: https://medicaldigest.org/scientific-contents/interview:switch-swedeheart-switching-ticagrelor-prasugrel-acs

From Guidelines to Clinical Impact: Key Takeaways on GDMT Implementation – Report from ESC 2026 Sep 10, 2026 00:07:46 Prof. Piotr Ponikowski discusses the critical gap between heart failure guidelines and real-world clinical practice, exploring the missing pieces needed for successful guideline-directed medical therapy (GDMT) implementation.Video: https://medicaldigest.org/scientific-contents/interview:guidelines-clinical-impact-key-takeaways-gdmt-implementation-report-esc-2026

Start Early, Start in Hospital: Translating Heart Failure Guidelines into Practice - report from ESC 2026 Sep 10, 2026 00:06:05 Prof. Shelley Zieroth addresses the critical importance of early, in-hospital initiation of guideline-directed medical therapy for heart failure at the ESC Congress 2026, highlighting practical strategies to improve patient outcomes during post-discharge transition.Video: https://medicaldigest.org/scientific-contents/interview:start-early-start-hospital-translating-heart-failure-guidelines-practic

Main Highlights and Key Clinical Takeaways of ESC 2026 Sep 10, 2026 00:05:13 Prof. Felix Mahfoud summarizes the main highlights and key clinical takeaways from the ESC Congress 2026, showcasing practice-changing trial results, new guidelines, and breakthroughs across AI, cardiometabolic disease, and interventional cardiology.Video: https://medicaldigest.org/scientific-contents/interview:main-highlights-and-key-clinical-takeaways-esc-2026

From Guidelines to Clinical Impact: GDMT Implementation - report from ESC 2026 Sep 10, 2026 00:06:55 Prof. Giuseppe Rosano addresses key challenges in implementing guideline-directed medical therapy at the ESC Congress 2026, exploring strategies to bridge the gap between clinical recommendations and real-world cardiovascular care.Video: https://medicaldigest.org/scientific-contents/interview:guidelines-clinical-impact-gdmt-implementation

SINGLE-AF: Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk - report from ESC 2026 Sep 10, 2026 00:05:23 Prof. Boyoung Joung presents findings from the landmark SINGLE-AF trial at the ESC Congress 2026. The study demonstrates that direct oral anticoagulants (DOACs) significantly reduce stroke risk in atrial fibrillation patients at intermediate risk without increasing major bleeding.Video: https://medicaldigest.org/scientific-contents/interview:single-af-anticoagulation-atrial-fibrillation-intermedia

ENRICH-AF: Edoxaban in Intracranial Hemorrhage Survivors with Atrial Fibrillation - report from ESC 2026 Sep 10, 2026 00:05:39 Prof. Ashkan Shoamanesh presents key findings from the ENRICH-AF trial at the ESC Congress 2026. The study evaluates whether edoxaban safely reduces stroke risk in high-risk atrial fibrillation patients with a history of intracranial hemorrhage, highlighting crucial trade-offs between ischemic stroke prevention and major bleeding risks. Video: https://medicaldigest.org/scientific-contents/intervie

5th Universal Definition of Myocardial Infarction - report from ESC 2026 Sep 10, 2026 00:07:18 Prof. Kristin Newby breaks down the new 5th Universal Definition of Myocardial Infarction at the ESC Congress 2026, highlighting refined diagnostic criteria and global clinical consensus.Video: https://medicaldigest.org/scientific-contents/interview:5th-universal-definition-myocardial-infarction

2026 ESC Guidelines on Cardiac Rehabilitation Sep 10, 2026 00:07:20 Prof. Matthias Wilhelm outlines the updated 2026 ESC Guidelines on Cardiac Rehabilitation at the ESC Congress 2026, focusing on personalized training and modern secondary prevention strategies.Video: https://medicaldigest.org/scientific-contents/interview:2026-esc-guidelines-cardiac-rehabilitation

Control the modifiable risk factors to prevent dementia: Insights from the 10/66 studies Jul 28, 2026 00:08:52 Professor Daisy Acosta delivers an essential expert overview on the shifting landscape of dementia prevalence across Latin America, building on crucial insights from the 10/66 studies. This concise brief highlights the unexpected increase in dementia prevalence over the past two decades across multiple catchment sites, contrasting sharply with the declining trends observed in high-income countries

The New Landscape of Alzheimer’s Therapy: Targets, Treatments, and Future Outlook Jul 22, 2026 00:13:15 Professor Takaomi C. Saido, world renowned scientist, delivers a comprehensive expert overview on the current state of Alzheimer's disease research, moving past traditional models to explore groundbreaking therapeutic targets. This concise brief highlights the mechanisms behind approved disease-modifying therapies, the crucial role of neprilysin and somatostatin receptor in amyloid clearance,

Highlights of ISTH Guidelines and Guidance Documents - report from ISTH 2026 Jul 21, 2026 00:06:05 Dr. James Douketis delivers an essential overview of the key highlights from the newly updated ISTH guidelines and guidance documents at the ISTH 2026 Congress. This targeted brief focuses on practical, evidence-based clinical recommendations, highlighting two major clinical updates:Surgical and Procedural Bleed Risk Stratification for Anticoagulated Patients Undergoing Planned Surgery – A refined

Updated recommendations on the diagnosis and classification of FXIII deficiencies / ISTH 2026 Diagnostic Highlights Jul 21, 2026 00:04:00 Dr. Zsuzsanna Bagoly presents the highly anticipated updated clinical recommendations for the diagnosis and classification of Factor XIII (FXIII) deficiencies at the ISTH 2026 Congress. This essential brief outlines the revised diagnostic algorithms, standardized laboratory assays, and clear classification pathways designed to improve the detection and management of this underdiagnosed, life-threa

Future Anticoagulants - report from ISTH 2026 Jul 21, 2026 00:05:06 Dr. Marco Donadini highlights the next generation of antithrombotic therapies at the ISTH 2026 Congress, featuring these breakthrough presentations:- A Synthetic, Allosteric, Highly Selective, Reversible Inhibitor of Human Factor XIa for Venous and Lung (Cancer-Associated) Thrombosis – Umesh Desai (Richmond, US)- EXocite ACTive site (EXACT) Inhibitors as Potent RNA Aptamer-Based Anticoagulants Tar

Anticoagulant Associated Bleeding: Specific Populations and Reversal - report from ISTH 2026 Jul 21, 2026 00:06:42 Dr. Kerstin de Wit highlights critical updates on anticoagulant-associated bleeding risks, management, and reversal strategies presented at the ISTH 2026 Congress, featuring the following key studies:- Perioperative Anticoagulation Management and Outcomes in Thrombotic Antiphospholipid Syndrome: A Single-Center Cohort Study – Miguel Paquette (Ottawa, Canada)- The Incidence and Outcomes of LMWH-Rel

Acute and Long-Term Management of Severe DVT by ESVM VTE Guideline - report from ISTH 2026 Jul 21, 2026 00:06:19 Dr. Oliver Schlager outlines the acute and long-term management of severe deep vein thrombosis (DVT) in alignment with the ESVM VTE Guidelines at the ISTH 2026 Congress. This brief highlights key recommendations for early intervention, tailored anticoagulation duration, and strategies to minimize the risk of post-thrombotic syndrome (PTS).Video: https://medicaldigest.org/scientific-contents/interv

Introductions to the ISTH Guidelines and Guidance Documents - report from ISTH 2026 Jul 21, 2026 00:05:45 Dr. Fionnuala Ní Áinle presents an essential overview of the latest ISTH Guidelines and Guidance Documents at the ISTH 2026 Congress. This brief highlights key clinical recommendations, the methodological rigor behind the guidelines, and practical implementation strategies to standardize care in thrombosis and hemostasis globally.Video: https://medicaldigest.org/scientific-contents/interview:intro

Cancer-Associated Thrombosis & Hemostasis - report from ISTH 2026 Jul 21, 2026 00:12:06 Dr. Darko Antic presents key insights into the complex management of cancer-associated thrombosis (CAT) and hemostasis at the ISTH 2026 Congress. This brief highlights the latest clinical evidence on anticoagulation strategies, balancing bleeding versus recurrent thrombotic risks, and customizing treatment pathways for oncological patients.Video: https://medicaldigest.org/scientific-contents/inter

VTE Diagnosis: What's New? - report from ISTH 2026 Jul 21, 2026 00:08:40 Dr. Aurélien Delluc highlights key advancements in Venous Thromboembolism (VTE) diagnosis from the ISTH 2026 Congress. Video: https://medicaldigest.org/scientific-contents/interview:vte-diagnosis-whats-new

Novelties in the Treatment of Alzheimer's Disease Jul 21, 2026 00:06:54 Dr. Rebecca Edelmayer presents an inspiring overview of the latest breakthroughs and novelties in the treatment of Alzheimer's disease at the AAIC 2026 Congress.Video: https://medicaldigest.org/scientific-contents/interview:novelties-treatment-alzheimers-disease

Highlights of the AAIC 2026 Congress Jul 21, 2026 00:13:15 Dr. Courtney Kloske delivers a highly anticipated expert overview of the most impactful breakthroughs and scientific updates presented at the AAIC 2026 Congress. This concise brief highlights accelerated advances in early diagnostics, emerging multi-omics approaches, key clinical trial outcomes, and global initiatives shaping the future of Alzheimer's and dementia research.Video: https://medic

Targeting CD19+ B-Cells in IgG4-Related Disease: Clinical Evidence and Implications for Long-Term Management - Report from EULAR 2026 Jun 15, 2026 00:15:18 Dr. Emanuel Della Torre discusses the clinical evidence behind targeting CD19+ B-cells in IgG4-related disease in a post-congress interview following EULAR 2026. This recap focuses on the therapeutic impact of these strategies, underlying immunological mechanisms, and the long-term management implications for patients in clinical practice.Video: https://medicaldigest.org/scientific-contents/interv

State-of-the-Art Treatment in Psoriatic Arthritis - Report from EULAR 2026 Jun 15, 2026 00:23:50 Professor Laura C. Coates highlights the rapidly evolving landscape of state-of-the-art treatments for psoriatic arthritis (PsA) in a post-congress interview following EULAR 2026. This recap focuses on personalized management pathways, novel targeted therapies, and strategic frameworks aimed at optimizing long-term patient outcomes.Video: https://medicaldigest.org/scientific-contents/interview:sta

The RA Paradigm Shift: New Insights into Pathogenesis and a Pipeline of Promise - Report from EULAR 2026 Jun 15, 2026 00:05:46 Professor Elena Nikiphorou discusses the ongoing paradigm shift in rheumatoid arthritis (RA), presented at the EULAR 2026 Congress. This recap focuses on novel insights into RA pathogenesis and explores the promising therapeutic pipeline, highlighting how these scientific advancements are translating into more targeted, effective management strategies for clinical practice.Video: https://medicaldi

Systemic Sclerosis: Deciphering Pathogenesis, Unveiling Comorbidities, and Paving the Way for Targeted Treatment - Report from EULAR 2026 Jun 15, 2026 00:10:47 Professor Oliver Distler dives into the complex landscape of systemic sclerosis (SSc), presented at the EULAR 2026 Congress. This recap focuses on recent breakthroughs in deciphering SSc pathogenesis, identifying and managing critical comorbidities, and evaluating emerging therapeutic strategies that pave the way for highly targeted clinical treatments.Video: https://medicaldigest.org/scientific-c

EULAR / ACR Classification Criteria for Anti-Synthetase Syndrome - Report from EULAR 2026 Jun 15, 2026 00:06:07 Professor Lorenzo Cavagna discusses the developed EULAR / ACR classification criteria for anti-synthetase syndrome, presented at the EULAR 2026 Congress. This recap highlights the critical diagnostic parameters, clinical features, and serological markers involved in these standardized criteria, aiming to improve early recognition and harmonize research and patient care globally.Video: https://medi

Workflow in Focus: Advancing Global Health in Rheumatology - Report from EULAR 2026 Jun 15, 2026 00:04:09 Professor Annelies Boonen explores systemic workflows and their critical role in advancing global healthcare within rheumatology, presented at the EULAR 2026 Congress. This recap highlights optimized clinical pathways, health economics, and strategic workflow improvements designed to enhance patient care and sustainability on a global scale.Video: https://medicaldigest.org/scientific-contents/inte

Diagnosing Osteoporosis in Inflammatory Rheumatic Conditions - Report from EULAR 2026 Jun 15, 2026 00:06:29 Professor Radmila Matijevic addresses the complexities of diagnosing osteoporosis within the context of inflammatory rheumatic conditions, presented at the EULAR 2026 Congress. This recap focuses on best practices for early identification, the impact of chronic inflammation on bone density, and diagnostic strategies to effectively assess fracture risk in this specific patient population.Video: htt

Biosimilars in Focus: Advancing Global Health in Rheumatology - Report from EULAR 2026 Jun 15, 2026 00:06:58 Professor Tore K. Kvien explores the evolving landscape of biosimilars and their vital role in advancing global healthcare within rheumatology, presented at the EULAR 2026 Congress. This recap highlights clinical application, access strategies, and the overall impact of biosimilar therapies in improving patient outcomes and healthcare sustainability on a global scale.Video: https://medicaldigest.o

Treating Hypertension in the Elderly: Insights from the ESH Congress Jun 15, 2026 00:08:23 Dr. Paul Whelton shares critical insights from the ESH Congress on the management of hypertension in the elderly. While high blood pressure is highly prevalent in older age and carries an elevated cardiovascular risk, clinical practice often overestimates the risks of treatment. This expert overview challenges common misconceptions, highlighting how the elderly are frequently undertreated and emph

Screen, Monitor and Manage CTD-ILD: Practical Application of ERS/EULAR Guidelines and Expert Insights - Report from EULAR 2026 Jun 15, 2026 00:06:57 Dr. Francesco Del Galdo discusses the screening, monitoring, and management of connective tissue disease-associated interstitial lung disease (CTD-ILD), presented at the EULAR 2026 Congress. This recap focuses on the practical application of the joint ERS/EULAR guidelines, highlighting key diagnostic steps, monitoring tools, and therapeutic strategies to handle lung involvement in clinical practic

Treatment of Rheumatoid Arthritis Associated Interstitial Lung Disease - Report from EULAR 2026 Jun 15, 2026 00:03:41 Dr. Philippe Dieudé discusses current strategies for treating interstitial lung disease associated with rheumatoid arthritis (RA-ILD), presented at the EULAR 2026 Congress. This recap focuses on the management of pulmonary complications, the selection of appropriate immunosuppressive or antifibrotic therapies, and the clinical approach needed to stabilize lung function in these patients.Video: htt

Promote Happiness: Rethinking Care for Brighter Outcomes in Older Adults with RMDs - Report from EULAR 2026 Jun 15, 2026 00:10:36 Dr. José Antonio P. Da Silva discusses the importance of promoting happiness and well-being in older adults living with rheumatic and musculoskeletal diseases (RMDs), presented at the EULAR 2026 Congress. This recap focuses on rethinking traditional care models by incorporating psychological health and positive outcomes alongside standard medical management to improve the overall quality of life f

Improving Care in Spondyloarthritis: A Multidisciplinary Approach to the Disease and Its Extra-Musculoskeletal Manifestations - Report from EULAR 2026 Jun 15, 2026 00:04:42 Dr. Filip Van den Bosch discusses strategies for improving care in spondyloarthritis, presented at the EULAR 2026 Congress. This recap focuses on the practical use of a multidisciplinary approach to manage both joint symptoms and extra-musculoskeletal manifestations, such as uveitis, psoriasis, and inflammatory bowel disease, to achieve better overall patient outcomes.Video: https://medicaldigest.

HPR Sessions at EULAR 2026 Jun 15, 2026 00:03:28 Dr. Mwidimi Ndosi provides an overview of the key Health Professionals in Rheumatology (HPR) sessions at the EULAR 2026 Congress. This recap highlights the main topics discussed, including collaborative care models, the expanding role of non-physician specialists, and practical strategies implemented to enhance multidisciplinary teamwork in daily clinical practice.Video: https://medicaldigest.org/

The Patient is in the Middle - Report from EULAR 2026 Jun 15, 2026 00:04:42 Dr. Mwidimi Ndosi explains the role of patient-centered care in rheumatology, presented at the EULAR 2026 Congress. This recap covers the practical use of shared decision-making and how involving the patient in the care team helps improve treatment adherence and clinical outcomes.Video: https://medicaldigest.org/scientific-contents/interview:patient-middle

Secukinumab in Polymyalgia Rheumatica: Results of the Phase 3 REPLENISH Trial - Report from EULAR 2026 Jun 15, 2026 00:04:16 Dr. Christian Dejaco presents highly anticipated data from the Phase 3 REPLENISH trial, evaluating the efficacy and safety of secukinumab in patients with Polymyalgia Rheumatica (PMR), highlighted at the EULAR 2026 Congress. This breakthrough recap examines how targeting the IL-17A pathway provides a powerful steroid-sparing therapeutic alternative, significantly improving clinical remission rates

No Pain is THE Gain in Rheumatoid Diseases - Report from EULAR 2026 Jun 15, 2026 00:10:29 Dr. Lars Arendt-Nielsen delivers a compelling expert perspective on revolutionizing treatment priorities in rheumatic and musculoskeletal diseases, featured at the EULAR 2026 Congress. This brief explores the complex mechanisms of chronic pain, moving beyond traditional inflammatory markers to emphasize that achieving true, long-term pain remission is the ultimate measure of therapeutic success an

Unveiling Novel Antibodies and Their Practical Implication in RMDs - Report from EULAR 2026 Jun 15, 2026 00:07:23 Dr. Diane van der Woude provides a fascinating expert overview of the discovery of novel autoantibodies and their clinical translation in rheumatic and musculoskeletal diseases (RMDs), presented at the EULAR 2026 Congress. This recap highlights the latest breakthroughs in biomarker identification, how these emerging antibody profiles refine early diagnosis and risk stratification, and their practi

HPR: Patient Education, Support and Improving Access to Rheumatology Care - Report from EULAR 2026 Jun 15, 2026 00:03:55 Rikke Helene Moe, EULAR Vice-President HPR, delivers an inspiring expert overview of the vital role Health Professionals in Rheumatology (HPR) play in transforming patient care, highlighted at the EULAR 2026 Congress. This brief focuses on the latest advancements in structured patient education, comprehensive support frameworks, and innovative multi-disciplinary strategies aimed at breaking down b

Pain Management in Rheumatological Diseases - Report from EULAR 2026 Jun 15, 2026 00:05:23 Dr. Jasminka Milas-Ahic provides a comprehensive expert overview of the contemporary challenges and advancements in pain management across rheumatological diseases, presented at the EULAR 2026 Congress. This recap explores the critical shift toward multimodal treatment strategies, the integration of pharmacological and non-pharmacological interventions, and how addressing centralized pain mechanis

Managing Comorbidities in Systemic Sclerosis to Achieve Better Outcome - Report from EULAR 2026 Jun 15, 2026 00:07:59 Dr. Claudia Iannone delivers a vital expert perspective on the strategic management of comorbidities in patients with Systemic Sclerosis, featured at the EULAR 2026 Congress. This brief emphasizes the profound impact of overlapping systemic, cardiovascular, and metabolic complications on disease progression, highlighting the integrated care approaches and proactive screening protocols essential fo

Managing Comorbidities in Rheumatoid Arthritis for Better Outcome - Report from EULAR 2026 Jun 15, 2026 00:06:01 Dr. Claudia Iannone delivers a vital expert perspective on the strategic management of comorbidities in patients with Rheumatoid Arthritis, featured at the EULAR 2026 Congress. This brief emphasizes the profound impact of cardiovascular, metabolic, and mental health conditions on RA progression, highlighting integrated care approaches and early screening protocols essential for optimizing long-ter

Novel Development in Treatment of Lupus - Report from EULAR 2026 Jun 15, 2026 00:04:59 Dr. Anca Dinu Askanase provides an essential expert overview of the latest breakthrough advancements and novel therapeutic developments in the treatment of Systemic Lupus Erythematosus (SLE), presented at the EULAR 2026 Congress. This recap highlights the evolving paradigm of targeted biologics, innovative small molecules, and combination strategies designed to achieve deeper clinical remission, m

Impact of Sonelokimab on Clinical and Imaging Outcomes in Axial Spondyloarthritis: Results of a Phase 2 Study - Report from EULAR 2026 Jun 15, 2026 00:04:15 Professor Xenofon Baraliakos, President of EULAR, presents pivotal data from a Phase 2 study evaluating the impact of sonelokimab, an IL-17A/F-inhibiting Nanobody, on clinical outcomes in axial spondyloarthritis. Highlighted at the EULAR 2026 Congress, this breakthrough recap explores how the integration of advanced 18F-NaF PET imaging and MRI provides unprecedented visualization of reduced bone i

From Diagnosis to Family Building: Navigating Fertility in RMDs - Report from EULAR 2026 Jun 15, 2026 00:09:18 Dr. Laura Andreoli and Dr. Karen Schreiber share essential insights from EULAR 2026 on managing fertility and family planning in patients with rheumatic and musculoskeletal diseases (RMDs). This recap explores clinical strategies from early diagnosis to pregnancy, focusing on safe medication management, patient counseling, and the multidisciplinary support needed to ensure positive maternal and fe

Novel Treatment Horizons in Lupus: Key Updates from EULAR 2026 Jun 15, 2026 00:02:50 Dr. Victoria Werth provides a concise update on the rapidly evolving therapeutic landscape for lupus, highlighting breakthrough data from EULAR 2026. This recap focuses on novel, targeted therapies designed to address unmet needs in both systemic (SLE) and cutaneous lupus (CLE), exploring how these precision strategies are successfully reshaping disease modification.Video: https://medicaldigest.or

Highlights of EULAR 2026 Jun 15, 2026 00:04:42 Professor Xenofon Baraliakos, President of EULAR, delivers an authoritative executive summary of the definitive highlights from the EULAR 2026 Congress in London. Reflecting on a record-breaking year of scientific submissions, this overview captures the most impactful advancements spanning basic translational research, groundbreaking clinical trials in rheumatology, and newly updated management gu

Chest HRCT in Detecting, Staging and Follow Up of SARD-ILD - Report from EULAR 2026 Jun 15, 2026 00:04:49 Dr. Muriel Elhai provides an essential expert overview of the critical role of chest high-resolution computed tomography (HRCT) in systemic autoimmune rheumatic disease-associated interstitial lung disease (SARD-ILD), presented at the EULAR 2026 Congress. This recap highlights the latest advancements in early HRCT screening protocols, radiographic staging techniques, and optimal monitoring strateg

Clinical Manifestations and Disease Course in Systemic Sclerosis - Report from EULAR 2026 Jun 15, 2026 00:13:37 Dr. Cristiana Sieiro Santos delivers a vital expert analysis on the heterogeneous clinical manifestations and unpredictable disease course of Systemic Sclerosis, featured at the EULAR 2026 Congress. This brief highlights the crucial updates in early risk stratification, the progression of organ-specific complications like interstitial lung disease (ILD), and how deep clinical phenotyping is drivin

Under the Surface: New Perspectives in Lupus with TLR7/8 Inhibition - Report from EULAR 2026 Jun 15, 2026 00:02:38 Dr. Victoria Werth provides an expert analysis of the EULAR 2026 session exploring the role of Toll-like receptor 7 and 8 (TLR7/8) inhibition in systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE). This recap looks beneath the surface at the underlying pathogenic mechanisms of the disease, highlighting the latest clinical data and new therapeutic perspectives on how targetin

Transitioning Young Patients with Autoinflammatory Diseases to Adult Care: Implications for Daily Clinical Management - Report from EULAR 2026 Jun 15, 2026 00:09:50 Dr. Marco Gattorno provides an essential overview of the EULAR 2026 session focused on the transition of young patients with autoinflammatory diseases from pediatric to adult rheumatology care. This recap highlights the practical and clinical implications for daily medical management, emphasizing the need for structured multidisciplinary protocols. The discussion explores how to maintain treatment

Advanced Management in Rheumatoid Arthritis: Critical Updates from EULAR 2026 Jun 15, 2026 00:09:33 Professor Ruxandra Ionescu delivers an expert overview of the EULAR 2026 session dedicated to the advanced management of Rheumatoid Arthritis. This comprehensive recap explores the latest clinical evidence, emerging therapeutic pathways, and refined treat-to-target protocols designed to address complex, difficult-to-treat cases. The discussion highlights practical strategies for optimizing long-te

Tired Is Not Just a State of Mind: Addressing Pathological Fatigue at EULAR 2026 Jun 15, 2026 00:09:42 Dr. Elena Elefante provides an expert look into the EULAR 2026 joint session "Tired is not just a state of mind," focusing on the clinical realities of pathological fatigue in patients with rheumatic and musculoskeletal diseases (RMDs). This overview dives into how chronic fatigue is increasingly recognized as a complex biological symptom rather than a purely psychological state. The rec

Assessment of Disease Activity in Psoriatic Arthritis - Report from EULAR 2026 Jun 15, 2026 00:04:59 Dr. Michael Zauner provides a comprehensive expert overview of the latest advancements in assessing disease activity in Psoriatic Arthritis, presented at the EULAR 2026 Congress. This recap explores the evolving role of multi-domain assessment tools, the integration of patient-reported outcomes, and how more precise tracking measures are shaping modern treat-to-target strategies to improve long-te

The Benefits of Glucagon/GLP-1 Receptor Dual Agonism: Insights from the SYNCHRONIZE™ Phase 3 Studies of Survodutide Jun 14, 2026 00:12:27 Dr. Carel le Roux delivers an expert overview of the highly anticipated findings from the SYNCHRONIZE™ Phase 3 clinical studies, presented at the ADA Scientific Sessions. The discussion focuses on the clinical benefits of glucagon/GLP-1 receptor dual agonism, showcasing new data on survodutide. This recap highlights how targeting both pathways offers a powerful approach to weight management and me

Episodes

Recommended